Quick question - if assay is good and accepted by the FDA, what happens next? is there another 3-6 months review period for FDA to review the whole BLA package? Or is it more likely a rolling review - i.e. FDA only reviews the additional assay data provided assuming they are satisfied with all the other data in the package sitting with them for ages.
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure, page-218
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.015(1.36%) |
Mkt cap ! $1.278B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.10 | $7.169M | 6.411M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7296 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 43068 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |